Mayer-Kuckuk Philipp, Doubrovin Mikhail, Gusani Niraj J, Gade Terence, Balatoni Julius, Akhurst Tim, Finn Ronald, Fong Yuman, Koutcher Jason A, Larson Steven, Blasberg Ronald, Tjuvajev Juri Gelovani, Bertino Joseph R, Banerjee Debabrata
Molecular Pharmacology and Therapeutics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1281-91. doi: 10.1007/s00259-003-1143-z. Epub 2003 Mar 27.
Radionuclide imaging has been demonstrated to be feasible to monitor transgene expression in vivo. We hypothesized that a potential application of this technique is to non-invasively detect in deep tissue, such as cancer cells metastatic to the liver, a specific molecular response following systemic drug treatment. Utilizing human colon adenocarcinoma cells derived from a patient's liver lesion we first developed a nude rat xenograft model for colorectal cancer metastatic to the liver. Expression of a dihydrofolate reductase-herpes simplex virus 1 thymidine kinase fusion (DHFR-HSV1 TK) transgene in the hepatic tumors was monitored in individual animals using the tracer [(124)I]2'-fluoro-2'-deoxy-5-iodouracil-beta- d-arabinofuranoside (FIAU) and a small animal micro positron emission tomograph (microPET), while groups of rats were imaged using the tracer [(131)I]FIAU and a clinical gamma camera. Growth of the human metastatic colorectal cancer cells in the rat liver was detected using magnetic resonance imaging and confirmed by surgical inspection. Single as well as multiple lesions of different sizes and sites were observed in the liver of the animals. Next, using a subset of rats bearing hepatic tumors, which were retrovirally bulk transduced to express the DHFR-HSV1 TK transgene, we imaged the fusion protein expression in the hepatic tumor of living rats using the tracer [(124)I]FIAU and a microPET. The observed deep tissue signals were highly specific for the tumors expressing the DHFR-HSV1 TK fusion protein compared with parental untransduced tumors and other tissues as determined by gamma counting of tissue samples. A subsequent study used the tracer [(131)I]FIAU and a gamma camera to monitor two groups of transduced hepatic tumor-bearing rats. Prior to imaging, one group was treated with trimetrexate to exploit DHFR-mediated upregulation of the fusion gene product. Imaging in the living animal as well as subsequent gamma counting of tissue samples showed increased signal and tracer accumulation, respectively, as compared to the group not treated with the antifolate. It is concluded that the two examined nucleotide imaging methods are feasible techniques for monitoring of DHFR-HSV TK fusion protein expression in hepatic colorectal tumor tissue in living animals.
放射性核素成像已被证明可用于在体内监测转基因表达。我们推测,这项技术的一个潜在应用是在深部组织中,如转移至肝脏的癌细胞,无创检测全身药物治疗后的特定分子反应。利用源自患者肝脏病变的人结肠腺癌细胞,我们首先建立了一个裸鼠异种移植模型,用于研究转移至肝脏的结直肠癌。使用示踪剂[(124)I]2'-氟-2'-脱氧-5-碘尿嘧啶-β-D-阿拉伯呋喃糖苷(FIAU)和小动物微型正电子发射断层扫描仪(microPET),在个体动物中监测肝肿瘤中二氢叶酸还原酶-单纯疱疹病毒1胸苷激酶融合(DHFR-HSV1 TK)转基因的表达,而使用示踪剂[(131)I]FIAU和临床γ相机对大鼠组进行成像。使用磁共振成像检测大鼠肝脏中人转移性结直肠癌细胞的生长,并通过手术检查进行确认。在动物肝脏中观察到了不同大小和部位的单个以及多个病变。接下来,使用一组携带肝肿瘤的大鼠,这些大鼠通过逆转录病毒大量转导以表达DHFR-HSV1 TK转基因,我们使用示踪剂[(124)I]FIAU和microPET对活体大鼠肝肿瘤中的融合蛋白表达进行成像。通过对组织样本进行γ计数确定,与未转导的亲代肿瘤和其他组织相比,观察到的深部组织信号对表达DHFR-HSV1 TK融合蛋白的肿瘤具有高度特异性。随后的一项研究使用示踪剂[(131)I]FIAU和γ相机监测两组转导的携带肝肿瘤的大鼠。在成像前,一组用三甲曲沙治疗以利用DHFR介导的融合基因产物上调。与未用抗叶酸药物治疗的组相比,活体动物成像以及随后组织样本的γ计数分别显示信号和示踪剂积累增加。结论是,所研究的两种核苷酸成像方法是监测活体动物肝结直肠肿瘤组织中DHFR-HSV TK融合蛋白表达的可行技术。